Tesamorelin, Ipamorelin Blend 5+5 mg
The Tesamorelin and Ipamorelin blend is a synergistic research combination of two distinct growth hormone secretagogues. Tesamorelin is a GHRH analog highly researched for its lipolytic properties and visceral fat reduction, while Ipamorelin is a highly selective growth hormone secretagogue and ghrelin receptor agonist. This combination targets GHRH receptors and ghrelin receptors simultaneously to maximize growth hormone pulsatility and secretion.
Product Specifications
| Specification |
Tesamorelin |
Ipamorelin |
| Chemical Formula |
C221H366N72O67S |
C38H49N9O5 |
| Molecular Weight |
5135.89 g/mol |
711.86 g/mol |
| CAS Number |
901758-09-6 |
170851-70-4 |
| PubChem CID |
44147413 |
9831659 |
| Purity |
>99% (Guaranteed) |
| Physical State |
Lyophilized Powder (Sterile Vial) |
Key Research Applications
- Researching synergistic double-pathway GHRH/GHS somatotroph activation.
- Studying fat cell metabolism, visceral adipose tissue lipolysis, and lipid profiles.
- Exploring anabolic pathway stimulation and cellular growth in animal models.
- Investigating potential applications in metabolic research and age-related growth hormone studies.
Reconstitution & Reagent Handling
Reconstitute with sterile bacteriostatic water. Gently swirl to dissolve.
Storage & Stability
Store lyophilized powder at ≤8°C. Once reconstituted, keep refrigerated at 2°C to 8°C.
RESEARCH USE ONLY: This product is a high-purity laboratory chemical. It is synthesized and supplied strictly for laboratory research, in vitro studies, and experimental use. This product is not approved for human or veterinary use, diagnostic procedures, or therapeutic administration.